Although global viral hepatitis-related HCC incidence has plateaued, HBV remains the most common cause of HCC in Asia,28,29 as reflected in our clinical validation study (79.4% at Asian sites had HBV, and around 50% of these patients were treated with antiviral therapies, likely leading to normalized AFP levels).20 Here, AFP is linked to hepatocellular carcinoma.